These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37337143)

  • 1. Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota.
    Zhang J; Zhang C; Zhang Q; Yu L; Chen W; Xue Y; Zhai Q
    BMC Microbiol; 2023 Jun; 23(1):171. PubMed ID: 37337143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
    Macke L; Schulz C; Koletzko L; Malfertheiner P
    Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients.
    Li XB; Chu XJ; Cao NW; Wang H; Fang XY; Fan YG; Li BZ; Ye DQ
    BMC Microbiol; 2022 Apr; 22(1):117. PubMed ID: 35477382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling.
    Lau JT; Whelan FJ; Herath I; Lee CH; Collins SM; Bercik P; Surette MG
    Genome Med; 2016 Jul; 8(1):72. PubMed ID: 27363992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
    Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
    Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors affect the gut microbiome.
    Imhann F; Bonder MJ; Vich Vila A; Fu J; Mujagic Z; Vork L; Tigchelaar EF; Jankipersadsing SA; Cenit MC; Harmsen HJ; Dijkstra G; Franke L; Xavier RJ; Jonkers D; Wijmenga C; Weersma RK; Zhernakova A
    Gut; 2016 May; 65(5):740-8. PubMed ID: 26657899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
    Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
    Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Xiao X; Zhang X; Wang J; Liu Y; Yan H; Xing X; Yang J
    Gut; 2024 Jun; 73(7):1098-1109. PubMed ID: 38267200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Characteristics in Children After the Use of Proton Pump Inhibitors.
    Simakachorn L; Tanpowpong P; Chanprasertyothin S; Thongpradit S; Treepongkaruna S
    Turk J Gastroenterol; 2021 Jan; 32(1):70-75. PubMed ID: 33893768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and butyrate level changes associated with the long-term administration of proton pump inhibitors to old rats.
    Lee SM; Kim N; Nam RH; Park JH; Choi SI; Park YT; Kim YR; Seok YJ; Shin CM; Lee DH
    Sci Rep; 2019 Apr; 9(1):6626. PubMed ID: 31036935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
    Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
    mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.
    Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE
    Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of proton pump inhibitors on microbiota in chronic liver disease patients.
    Yamamoto K; Ishigami M; Honda T; Takeyama T; Ito T; Ishizu Y; Kuzuya T; Hayashi K; Goto H; Hirooka Y
    Hepatol Int; 2019 Mar; 13(2):234-244. PubMed ID: 30737678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH
    Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.
    Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B
    Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis Reveals Compositional and Functional Microbial Changes Associated with Osteoporosis.
    Akinsuyi OS; Roesch LFW
    Microbiol Spectr; 2023 Jun; 11(3):e0032223. PubMed ID: 37042756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
    Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
    Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.